Investing Ideas
/
Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies

Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

1 companies

UCB

Market Cap: €46.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

UCB

€243.00

2.2%

35.8%